Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News ZAI Laboratory ADR Representing Ord Shs ZLAB

Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late... see more

Current News (NDAQ:ZLAB)

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer

Business Wire 13 days ago

Zai Lab Announces Participation in Investor Conferences in March 2025

Business Wire March 3, 2025

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates

Business Wire February 27, 2025

Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025

Business Wire January 28, 2025

Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)

Business Wire January 22, 2025

Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia

Business Wire January 17, 2025

Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer

Business Wire January 15, 2025

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Business Wire January 10, 2025

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Business Wire January 10, 2025

Opinion & Analysis (NDAQ:ZLAB)

No current opinion is available.

Bullboard Posts (NDAQ:ZLAB)

ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conj

NEWS: $ZLAB ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and...
whytestocks - October 24, 2024

Zai Lab Limited: A Promising Biotech Player Poised for Signi

http://beyondspx.com/2024/08/02/zai-lab-limited-a-promising-biotech-player-poised-for-significant-growth/
MikeTester - August 3, 2024

Trend Tracker for (ZLAB)

BREAKING NEWS: $ZLAB Trend Tracker for (ZLAB)2024-06-15 21:38:00 ET Stock Traders Daily has produced this trading report using a...
whytestocks - June 15, 2024

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q

News; $ZLAB Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 | BenzingaAs of May 9, 2024, five stocks in the health care...
whytestocks - May 9, 2024

Zai Lab Announces Acceptance by China's NMPA of the BLA for

JUST IN: $ZLAB Zai Lab Announces Acceptance by China's NMPA of the BLA for Efgartigimod Alfa Injection (Subcutaneous Injection) for...
whytestocks - July 10, 2023

Why Shares of Zai Lab Are Dropping Wednesday

JUST IN: $ZLAB Why Shares of Zai Lab Are Dropping Wednesday2023-06-07 11:05:45 ET Shares of Zai Lab (NASDAQ: ZLAB) were down more than...
whytestocks - June 7, 2023